04:36 PM EDT, 07/09/2025 (MT Newswires) -- Inventiva ( IVA ) said late Wednesday it appointed Jason Campagna as chief medical officer and president of research and development.

Campagna succeeds Michael Cooreman, who is departing as chief medical officer. Co-founder and Chief Scientific Officer Pierre Broqua will transition to a consulting role as scientific advisor.

Campagna most recently was the chief medical officer at Q32 Bio ( QTTB ) , Inventiva ( IVA ) said.